LFST - LifeStance Health Group, Inc.
6.93
-0.020 -0.289%
Share volume: 2,952,760
Last Updated: 03-06-2026
Healthcare/Services – Health:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$6.95
-0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-07-2025 | 11-06-2025 | 02-25-2026 | |
| Total revenue | 300.437 M | 312.331 M | 312.722 M | 325.480 M | 332.970 M | 363.809 M | 382.195 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 300.437 M | 312.331 M | 312.722 M | 325.480 M | 332.970 M | 363.809 M | 382.195 M | |
| 3.96% | 0.13% | 4.08% | 2.30% | 9.26% | 5.05% | |||
| Operating expenses | 294.645 M | 309.678 M | 297.560 M | -538.821 M | 94.431 M | 95.615 M | 94.777 M | |
| Selling general and admin | 294.645 M | 309.678 M | 297.560 M | -538.821 M | 94.431 M | 95.615 M | 94.777 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 317.209 M | 328.278 M | 312.675 M | 324.421 M | 331.366 M | 356.399 M | 364.111 M | |
| 3.49% | -4.75% | 3.76% | 2.14% | 7.55% | 2.16% | |||
| Operating income | -16.772 M | -15.947 M | 47.000 K | 1.059 M | 1.604 M | 7.410 M | 18.084 M | |
| Ebit | -14.831 M | -16.798 M | 31.000 K | 520.000 K | 1.603 M | 7.386 M | 18.078 M | |
| Pretax income | -20.734 M | -22.621 M | -5.382 M | -8.876 M | -1.470 M | 4.572 M | 15.203 M | |
| 9.10% | -76.21% | 64.92% | -83.44% | -411.02% | 232.52% | |||
| Income tax | 363.000 K | 656.000 K | 575.000 K | -1.764 M | -2.179 M | 3.495 M | 3.535 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -21.097 M | -23.277 M | -5.957 M | -7.112 M | 709.000 K | 1.077 M | 11.668 M | |
| -10.33% | 74.41% | -19.39% | 109.97% | 51.90% | 983.38% |